NEUROFIT

Executive Summary

NEUROFIT is a preclinical Contract Research Organization (CRO) based in Paris, France, with over 25 years of experience in evaluating treatments for central and peripheral nervous system disorders. The company offers a comprehensive portfolio of in vitro and in vivo models across a wide range of neurological indications, aiming to accelerate preclinical drug development for pharmaceutical and biotech clients. As a specialized service provider, NEUROFIT benefits from the growing demand for outsourced neuroscience research, driven by increased R&D investment in areas such as Alzheimer's, Parkinson's, and rare neurological diseases. The company's long-standing presence in the field and cost-effective methods position it as a reliable partner for compound evaluation. However, limited public financial data and its private status make it challenging to assess growth metrics. With a focus on operational efficiency and scientific expertise, NEUROFIT is well-placed to capture a share of the expanding preclinical CRO market, though its near-term visibility depends on client wins and service expansions.

Upcoming Catalysts (preview)

• TBDLaunch of novel in vivo models for rare neurological indications60% success
• TBDStrategic partnership with a top-20 pharmaceutical company for CNS drug development40% success
• TBDExpansion of service portfolio into pain and neurodegeneration models70% success